1226830

Philip NMI Raskin — FEI 3008281994

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance